Cargando…

Co-alteration of EGFR mutation and ALK rearrangement in non-small cell lung cancer: Case series

RATIONALE: Current guidelines for advanced non-small cell lung cancer (NSCLC) recommend the use of targeted agents for specific driver genes after confirming genetic alterations. Although epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) rearrangement are usually...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Hong-Joon, Kho, Bo Gun, Kim, Min-Seok, Park, Ha Young, Kim, Tae-Ok, Kim, Yu-Il, Lim, Sung-Chul, Park, Cheol-Kyu, Kim, Young-Chul, Choi, Yoo-Duk, Oh, In-Jae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831261/ https://www.ncbi.nlm.nih.gov/pubmed/30817606 http://dx.doi.org/10.1097/MD.0000000000014699

Ejemplares similares

Feasibility of liquid biopsy using plasma and platelets for detection of anaplastic lymphoma kinase rearrangements in non-small cell lung cancer
por: Park, Cheol-Kyu, et al.
Publicado: (2019)

Feasibility of re‐biopsy and EGFR mutation analysis in patients with non‐small cell lung cancer
por: Kim, Tae‐Ok, et al.
Publicado: (2018)

Delayed diagnosis of lung cancer due to misdiagnosis as worsening of sarcoidosis: a case report
por: Shin, Hong-Joon, et al.
Publicado: (2020)

Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression
por: Park, Ha-Young, et al.
Publicado: (2019)

Quantification of epidermal growth factor receptor (EGFR) mutation may be a predictor of EGFR‐tyrosine kinase inhibitor treatment response
por: Park, Ha Young, et al.
Publicado: (2016)

The occult nodal metastasis rate of early tongue cancer (T1–T2): A protocol for a systematic review and meta-analysis
por: Choi, Kyu Young, et al.
Publicado: (2021)

BRAF V600E mutation as a novel mechanism of acquired resistance to ALK inhibition in ALK-rearranged lung adenocarcinoma: A case report
por: Sui, Aixia, et al.
Publicado: (2021)

Clinical course of non-small cell lung cancer patients with dry pleural dissemination: Retrospective observational study
por: Kim, Woojung, et al.
Publicado: (2020)

Breast metastasis from EGFR/ALK negative lung adenocarcinoma: A case report
por: Cao, Liyu, et al.
Publicado: (2020)

Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness
por: Kim, Tae-Ok, et al.
Publicado: (2021)

Can Thymidine Phosphorylase Be a Predictive Marker for Gemcitabine and Doxifluridine Combination Chemotherapy in Cholangiocarcinoma?: Case Series
por: Kang, Myoung Hee, et al.
Publicado: (2014)

Alectinib in the treatment of ocular metastases of ALK rearranged non small cell lung cancer: Description of 2 case reports
por: Gozzi, Elisa, et al.
Publicado: (2020)

Efficacy of immune checkpoint inhibitors according to PD‐L1 tumor proportion scores in non‐small cell lung cancer
por: Park, Seongho, et al.
Publicado: (2019)

Use of intrapulmonary administration of thrombin in hematological malignancy patients with alveolar haemorrhage: A case series
por: Lee, Jongmin, et al.
Publicado: (2020)

Interpretation and Prognostic Value of Positron Emission Tomography-Computed Tomography After Induction Chemotherapy With or Without Radiation in IIIA-N2 Non-small Cell Lung Cancer Patients Who Receive Curative Surgery
por: Kim, Sung Hwan, et al.
Publicado: (2015)

A randomized, multi-center, open-label study to compare the safety and efficacy between afatinib monotherapy and combination therapy of afatinib and HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations
por: Song, Si-Yeon, et al.
Publicado: (2020)

The prognostic implications of EGFR mutation and ALK rearrangement for the long‐term outcomes of patients with resected lung adenocarcinomas
por: Kim, Hyungjin, et al.
Publicado: (2019)

Clinical outcomes of tissue expanders on adjuvant radiotherapy of resected retroperitoneal sarcoma
por: Yu, Jeong Il, et al.
Publicado: (2016)

Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements
por: Cha, Yoon Jin, et al.
Publicado: (2014)

The Clinicopathologic Features and Treatment of 607 Hindgut Neuroendocrine Tumor (NET) Patients at a Single Institution
por: Kim, Seung Tae, et al.
Publicado: (2016)

Prognostic value of tumor volume and radiation dose in moderate-sized hepatocellular carcinoma: A multicenter analysis in Korea (KROG 14–17)
por: Kim, Myungsoo, et al.
Publicado: (2017)

Association of Metformin Use With Cancer-Specific Mortality in Hepatocellular Carcinoma After Curative Resection: A Nationwide Population-Based Study
por: Seo, Young-Seok, et al.
Publicado: (2016)

Clinical Correlation Between Tumor Maximal Standardized Uptake Value in Metabolic Imaging and Metastatic Tumor Characteristics in Advanced Non-small Cell Lung Cancer
por: Lee, Dong Soo, et al.
Publicado: (2015)

Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study
por: Na, Young-Ok, et al.
Publicado: (2022)

Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer
por: Park, Hwa Kyung, et al.
Publicado: (2023)

Clinical impact of boost irradiation to pelvic lymph node in uterine cervical cancer treated with definitive chemoradiotherapy
por: Choi, Kyu Hye, et al.
Publicado: (2018)

A rare double ALK fusion variant EML4-ALK and CDK15-ALK in lung adenocarcinoma and response to crizotinib: A case report
por: Guo, Jun, et al.
Publicado: (2020)

Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?
por: Chang, Jee Suk, et al.
Publicado: (2015)

Identification of triple gene fusion ALK-LRRN2, LTBP1-ALK, and HIP1-ALK in advanced lung adenocarcinoma and response to alectinib: A case report
por: Ning, Shangkun, et al.
Publicado: (2021)

Distinctive Patterns of Initially Presenting Metastases and Clinical Outcomes According to the Histological Subtypes in Stage IV Non-Small Cell Lung Cancer
por: Lee, Dong Soo, et al.
Publicado: (2016)

Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis
por: Roh, Tae Hoon, et al.
Publicado: (2017)

Paradoxical pulmonary hemorrhage associated with hemocoagulase batroxobin in a patient with hemoptysis: A CARE-compliant case report
por: Kim, Tae-Ok, et al.
Publicado: (2021)

Lifestyle interventions after colorectal cancer surgery using a mobile digital device: A study protocol for a randomized controlled trial
por: Kim, Young Il, et al.
Publicado: (2022)

PD‐L1 expression in ROS1‐rearranged non‐small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1
por: Lee, Jongmin, et al.
Publicado: (2018)

Integrative radiogenomic analysis for genomic signatures in glioblastomas presenting leptomeningeal dissemination
por: You, Hye Jin, et al.
Publicado: (2016)

CT features and disease spread patterns in ROS1-rearranged lung adenocarcinomas: comparison with those of EGFR-mutant or ALK-rearranged lung adenocarcinomas
por: Woo, Jung Han, et al.
Publicado: (2020)

Aggressively progressing primary undifferentiated pleomorphic sarcoma in the eyelid: A case report and review of the literature
por: Choi, Won, et al.
Publicado: (2017)

Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg®) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A randomized phase III clinical trial
por: Park, Kwonoh, et al.
Publicado: (2023)

A Phase II Trial of Osimertinib as the First-Line Treatment of Non–Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1
por: Park, Cheol-Kyu, et al.
Publicado: (2021)

Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer
por: Yoon, Seong-Hoon, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7i93ncfvrjjvr2nbu8pap8ehb6